Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 9 (3) , 331-337
- https://doi.org/10.1016/0168-8278(89)90142-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1988
- Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferonHepatology, 1987
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infectionGastroenterology, 1987
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type BHepatology, 1986
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver diseaseJournal of Hepatology, 1985
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981